- Report
- March 2025
- 147 Pages
Global
From €2147EUR$2,250USD£1,799GBP
- Report
- January 2025
- 165 Pages
Global
From €2720EUR$2,850USD£2,279GBP
- Report
- August 2024
- 175 Pages
Global
From €4772EUR$5,000USD£3,998GBP
- Report
- March 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- February 2025
- 200 Pages
Global
From €4285EUR$4,490USD£3,590GBP
- Report
- December 2024
- 150 Pages
Global
From €3579EUR$3,750USD£2,999GBP
- Report
- April 2023
- 112 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- July 2022
- 146 Pages
Global
From €4247EUR$4,450USD£3,558GBP
- Report
- July 2018
- 50 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- September 2022
- 104 Pages
Europe
From €1432EUR$1,500USD£1,199GBP
- Report
- April 2020
- 49 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Book
- February 2011
- 488 Pages
- Book
- September 2022
- 480 Pages
- Book
- April 2009
- 120 Pages
- Book
- March 2009
- 278 Pages

Atherosclerosis is a condition in which plaque builds up in the walls of arteries, leading to a narrowing of the arteries and reduced blood flow. It is a major cause of cardiovascular disease, including heart attack and stroke. Atherosclerosis is a major focus of cardiology, as it is the leading cause of death in the United States. Treatment of atherosclerosis involves lifestyle changes, such as diet and exercise, as well as medications to reduce cholesterol and blood pressure. In some cases, surgery may be necessary to open blocked arteries.
The atherosclerosis market is a rapidly growing segment of the cardiology market, driven by an aging population and increasing prevalence of cardiovascular disease. The market is expected to continue to grow in the coming years, driven by advances in medical technology and the development of new treatments.
Companies in the atherosclerosis market include Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more